Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar;164(3):1151-1159.
doi: 10.1002/ijgo.15211. Epub 2023 Nov 21.

The global burden of disease due to benign gynecological conditions: A call to action

Dileep Wijeratne  1 , Joanna F E Gibson  1 , Alison Fiander  2 , Elizabeth Rafii-Tabar  3 , Ranee Thakar  4
Affiliations

The global burden of disease due to benign gynecological conditions: A call to action

Dileep Wijeratne et al. Int J Gynaecol Obstet. 2024 Mar.

Abstract

Objective: Focusing on low- and middle-income countries (LMICs), this article uses data from the Global Burden of Disease (GBD) database to highlight the burden of morbidity due to benign gynecological conditions (BGCs).

Methods: We analyzed 2019 morbidity data for all BGCs, measured as years lost to disability (YLDs). Disease burden was calculated for individual conditions, BGCs overall, and percentages of overall disease burden from all conditions. The same data extraction was performed for malaria, tuberculosis, and HIV/AIDS for comparison. The data were subcategorized by age and World Bank income level.

Results: BGCs are major causes of disease morbidity worldwide. For women aged 15 years and over in high-income countries (HICs), 3 588 157 YLDs (3.94% of all YLDs) were due to BGC. In LMICs, 18 242 989 YLDs (5.35% of all YLDs) were due to BGCs. The highest burden of BGCs is seen during the reproductive years where conditions driven or exacerbated by reproductive hormones are the major causes of morbidity. In LMICs, for women aged 15-49, 14 574 100 YLDs (7.75% of all YLDs) were due to BGCs, declining to 3 152 313 YLDs (3.04%) in women aged 50-69 and 529 399 YLDs (1.06%) in women age 70+.

Conclusion: These data demonstrate a huge burden of morbidity due to BGCs. There is an urgent need for international stakeholders to prioritize the treatment and prevention of BGCs.

Keywords: abortion; global women's health; gynecology; inequality; menstrual; morbidity; reproductive health.

PubMed Disclaimer

References

REFERENCES

    1. Wijeratne D, Fiander A. Gynaecological disease in the developing world: a silent pandemic. Obstet Gynaecol. 2018;20(4):237-244.
    1. Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204-1222. Accessed May 18, 2021. https://pubmed.ncbi.nlm.nih.gov/33069326/
    1. Arafa A, Saleh L, Shawky S. Association between menstrual disorders and school absenteeism among schoolgirls in South Egypt. Int J Adolesc Med Health. 2019;34(1). doi:10.1515/ijamh-2019-0081
    1. Mishra GD, Anderson D, Schoenaker DAJM, et al. InterLACE: a new international collaboration for a life course approach to Women's reproductive health and chronic disease events. Maturitas. 2013;74(3):235-240. Accessed Aug 4, 2022. http://www.maturitas.org/article/S0378512212004112/fulltext
    1. Women's Reproductive Health (InterLACE): Case Study|NHMRC. Cited Nov 28, 2022. https://www.nhmrc.gov.au/about-us/resources/impact-case-studies/womens-r...

LinkOut - more resources